Contract for the supply of medicinal products included in the list referred to in Article 266a(2) of the Medicinal Products in Human Medicine Act - medicinal products bearing an international non-proprietary name (INN) - Busulfan and Melphalan Text automatically translated in your browsing language Automatically translated

The subject matter of the contract is the supply of medicinal products included in the list referred to in Article 266a(2) of the Medicinal Products in Human Medicine Act, concluded on the basis of Article 266a(5)(3) of the Medicinal Products in Human Medicine Act, in conjunction with Article 1(1)(2), Article 3(3), Article 15c(1) and Article 15b of Regulation No 10/17.11.2011 of the Ministry of Health, under which the Contractor agrees, after receiving a letter of agreement from the Executive Agency for Medicinal Products (IAMP) and a written request for the supply of medicinal products, to supply the following medicinal products, in the quantities prescribed by the Saint Marina University Hospital EAD with Protocol No 2 issued pursuant to Regulation No 10 of 17.11.2011, on an offer from the CONTRACTOR, namely medicinal products with an international non-proprietary name (INN) - Busulfan and Melphalan and the Commercial name/medicine form/quantity of the active substance: 1. Busulfan Tillomed 6mg/ml 10 ml concentrate for solution for infusion x 8.The estimated delivery amounts are 8 packs containing 8 vials per pack. 2. Melphalan 50 mg powder and solvent for injection/infusion x 1.The estimated delivery amounts are 50 packs containing 1 vial and 1 solvent per pack. The specified quantities of the medicinal products can be delivered according to one or several separate delivery requests, depending on the specific needs of the medical institution. The contracting authority is obliged to accept and pay only the quantity requested and delivered under the terms of the contract. Text automatically translated in your browsing language Automatically translated

33600000 - Pharmaceutical products